- 2022
- Press releases - 13.04.2022
Long COVID: When Symptoms Persist Months after the First Wave
Dans une nouvelle étude, des scientifiques ont identifié, à partir des données de près de 26 000 volontaires de la cohorte Constances, quels symptômes persistants sont le plus fréquemment rapportés par les personnes ayant été infectées par le SARS-CoV-2 comparé au reste de la population. Il s’agit principalement de la perte de goût ou d’odorat, de gêne respiratoire ou de fatigue.
- Press releases - 12.04.2022
New joint Declaration of Intent between the Quebec Health Research Fund and Inserm
Rémi Quirion, Quebec’s Chief Scientist, and Dr. Gilles Bloch, Chairman and Chief Executive Officer of the French National Institute of Health and Medical Research (Inserm), are pleased to announce the signing of a new joint Declaration of Intent between the Quebec Health Research Fund and Inserm. Covering the next four years, this declaration renews an institutional partnership spanning over half a century.
- Press releases - 12.04.2022
HIV: The Antibodies of “Post-treatment Controllers”
A very small percentage of people with HIV-1, known as “post-treatment controllers” (PTCs), are able to control their infection after interrupting all antiretroviral therapy. Understanding the fundamental mechanisms that govern their immune response is essential in order to develop HIV-1 vaccines, novel therapeutic strategies to achieve remission, or both. A recent study investigated the humoral immune response – also known as antibody-mediated immunity – in some PTCs in whom transient episodes of viral activity were observed. The researchers have shown their humoral immune response to be both effective and robust, which could help to control the infection in the absence of treatment.
- Press releases - 07.04.2022
Older Adults: Understanding and Preventing Barriers to an Active Lifestyle
Researchers have studied the impact of individual sociodemographic, behavioral and health factors on the practice of daily physical activity in later life, using data from 3,896 participants of the Whitehall II cohort. This research highlights the complexity of individual barriers to an active lifestyle among older adults and suggests that this complexity should be better taken into account when redefining public health policies.
- Press releases - 04.04.2022
Alzheimer’s Disease: The Identification of 75 Genetic Risk Factors Brings New Insights
Researchers have identified 75 regions of the genome that are associated with Alzheimer’s disease. Forty-two of these regions are novel, meaning that they have never before been implicated in the disease. The findings bring new knowledge of the biological mechanisms at play and open up new avenues for treatment and diagnosis.
- Press releases - 24.03.2022
Artificial Sweeteners: Possible Link to Increased Cancer Risk
In order to evaluate the risk of cancer linked to them, researchers analyzed data relating to the health of 102,865 French adults participating in the NutriNet-Santé cohort study and their consumption of artificial sweeteners. The results of these statistical analyses suggest a link between the consumption of artificial sweeteners and an increased risk of cancer.
- Press releases - 24.03.2022
La tenue d’un colloque à l’IHU intitulé « Premier bilan des connaissances et des controverses scientifiques… » interpelle, les membres fondateurs se mobilisent
L’ensemble des membres fondateurs s’interroge sur la tenue d’un tel évènement au sein d’un Institut hospitalo-universitaire. L’intitulé et la nature des participants et des associations partenaires ne laissent aucun doute sur les objectifs. Par conséquent, les membres fondateurs demandent la délocalisation de cette conférence.
- Press releases - 24.03.2022
Increased Ischemic Stroke Risk Associated with Certain Medications for Nausea and Vomiting
Studies have shown that the risk of ischemic stroke is increased by the use of antipsychotics: medications with antidopaminergic properties that are commonly prescribed in psychiatry. Researchers evaluated the ischemic stroke risk associated with exposure to other antidopaminergic medications—antiemetics, which are very commonly used in the symptomatic treatment of nausea and vomiting. The findings of this study, show a link between the use of these medications and the risk of ischemic stroke.
- Press releases - 21.03.2022
COVID-19: “Reactive” Vaccination, Effective in Case of High Viral Circulation?
A new modeling study by researchers from Inserm and Sorbonne Université at the Pierre Louis Institute of Epidemiology and Public Health shows that a “reactive” vaccination strategy targeting homes, schools and workplaces where cases are detected could have beneficial effects, reducing the number of COVID-19 cases in certain epidemic situations.
- Press releases - 16.03.2022
Discovery of an immune escape mechanism promoting Listeria infection of the central nervous system
Scientists have discovered a mechanism that enables cells infected with Listeria monocytogenes to escape immune responses. This mechanism provides infected cells circulating in the blood with a higher probability of adhering to and infecting cells of cerebral vessels, thereby enabling bacteria to cross the blood-brain barrier and infect the brain.